Highlights
- •Juvenile dermatomyositis is the most common idiopathic inflammatory myopathy of childhood.
- •Clinical features of juvenile dermatomyositis include proximal muscle weakness, rash, and joint pain.
- •Treatment guidelines published by the Childhood Arthritis and Rheumatology Research Alliance (CARRA) offer a consensus on the treatment of moderately severe juvenile dermatomyositis in the first 2 months after diagnosis.
Abstract
Patients presenting with progressive muscle weakness, who are otherwise ambulatory,
may be difficult to evaluate. The differential diagnoses for a pediatric patient with
progressively worsening weakness, heliotrope rash, joint pain, and fatigue can be
broad. This case challenge highlights the case of an 8-year-old girl who presents
with the aforementioned symptoms and will review important items in the history and
physical examination to consider when narrowing this list of differentials. Diagnostic
evaluation, management, and patient and family teaching are reviewed.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The Journal for Nurse PractitionersAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Muscular dystrophies.Clin Chest Med. 2018; 39: 377-389https://doi.org/10.1016/j.ccm.2018.01.004
- Juvenile idiopathic arthritis: oligoarthritis and polyarthritis.Pediatr Clin North Am. 2018; 65: 657-674https://doi.org/10.1016/j.pcl.2018.03.005
- Systemic juvenile idiopathic arthritis.Pediatr Clin North Am. 2018; 65: 691-709https://doi.org/10.1016/j.pcl.2018.04.005
- Immunopathogenesis of juvenile systemic sclerosis.Front Immunol. 2019; 10: 9-13https://doi.org/10.3389/fimmu.2019.01352
- Overview of juvenile localized scleroderma and its management.World J Pediatr. 2020; 16: 5-18https://doi.org/10.1007/s12519-019-00320-9
- Psoriasis pathogenesis and treatment.Int J Mol Sci. 2019; 20: 1-28https://doi.org/10.3390/ijms20061475
- Childhood-onset systemic lupus erythematosus: a review and update.J Pediatr. 2018; 196: 22-30.e2https://doi.org/10.1016/j.jpeds.2018.01.045
- Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.Lancet. 2008; 371: 2201-2212https://doi.org/10.1016/S0140-6736(08)60955-1
- The Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans: toward comparative effectiveness in the pediatric rheumatic diseases.Arthritis Rheumatol. 2018; 70: 669-678https://doi.org/10.1002/art.40395
- Consensus-based recommendations for the management of juvenile dermatomyositis.Ann Rheum Dis. 2017; 76: 329-340https://doi.org/10.1136/annrheumdis-2016-209247
- Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children’s Arthritis and Rheumatology Research Alliance Consensus Conference.Arthritis Care Res. 2010; 62: 219-225https://doi.org/10.1002/acr.20071
Biography
Anna Richmond, DNP, FNP-C, PNP-PC, is an assistant professor of nursing at Vanderbilt University of School of Nursing and the Department of Pediatrics at Monroe Carrell Jr. Children’s Hospital at Vanderbilt, Nashville, TN, and can be contacted at [email protected]
Article info
Publication history
Published online: March 03, 2022
Footnotes
In compliance with standard ethical guidelines, the author reports no relationships with business or industry that would pose a conflict of interest.
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
